Literature DB >> 14532211

Extended epidemic of nosocomial urinary tract infections caused by Serratia marcescens.

Lin-Hui Su1, Jonathan T Ou, Hsieh-Shong Leu, Ping-Cherng Chiang, Yueh-Pi Chiu, Ju-Hsin Chia, An-Jing Kuo, Cheng-Hsun Chiu, Chishih Chu, Tsu-Lan Wu, Chien-Feng Sun, Thomas V Riley, Barbara J Chang.   

Abstract

In recent years a significant increase in the incidence of Serratia marcescens infections was noted at the Chang Gung Memorial Hospital, Taoyuan, Taiwan. A review of laboratory (1991 to 2002) and infection control (1995 to 2002) records showed the possibility of an extended epidemic of nosocomial urinary tract infections (UTIs) caused by S. marcescens. Therefore, in 1998 and 1999, 87 isolates were collected from patients with such infections and examined and another 51 isolates were collected in 2001 and 2002. The patients were mostly elderly or the infections were associated with the use of several invasive devices. S. marcescens was usually the only pathogen found in urine cultures in our study. Neither prior infections nor disseminated infections with the organism were observed in these patients. Resistance to most antibiotics except imipenem was noted. Two genotyping methods, pulsed-field gel electrophoresis and infrequent-restriction-site PCR, were used to examine the isolates. A total of 12 genotypes were identified, and 2 predominant genotypes were found in 72 (82.8%) of the 87 isolates derived from all over the hospital. However, 63.9% of the isolates of the two genotypes were from neurology wards. A subsequent intervention by infection control personnel reduced the infection rate greatly. The number and proportion of the two predominant genotypes were significantly reduced among the 51 isolates collected in 2001 and 2002. Thus, a chronic and long-lasting epidemic of nosocomial UTIs caused by S. marcescens was identified and a successful intervention was carried out. Both a cautious review of laboratory and infection control data and an efficient genotyping system are necessary to identify such a cryptic epidemic and further contribute to the quality of patient care.

Entities:  

Mesh:

Year:  2003        PMID: 14532211      PMCID: PMC254321          DOI: 10.1128/JCM.41.10.4726-4732.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

1.  Molecular epidemiology of Salmonella enterica serovar Enteritidis isolated in Taiwan.

Authors:  Lin-Hui Su; Cheng-Hsun Chiu; Tsu-Lan Wu; Chishih Chu; Ju-Hsin Chia; An-Jing Kuo; Chia-Ching Lee; Chien-Feng Sun; Jonathan T Ou
Journal:  Microbiol Immunol       Date:  2002       Impact factor: 1.955

2.  Epidemiology and susceptibility of serratia marcescens in a large general hospital over an 8-year period.

Authors:  A Hejazi; H M Aucken; F R Falkiner
Journal:  J Hosp Infect       Date:  2000-05       Impact factor: 3.926

3.  Risk factors for acquisition of Serratia marcescens in a surgical intensive care unit.

Authors:  S van der Sar-van der Brugge; S M Arend; A T Bernards; G A Berbee; R G Westendorp; J D Feuth; P J van den Broek
Journal:  J Hosp Infect       Date:  1999-04       Impact factor: 3.926

4.  Molecular epidemiology of nosocomial infection associated with multi-resistant Acinetobacter baumannii by infrequent-restriction-site PCR.

Authors:  T-L Wu; L-H Su; H-S Leu; C-H Chiu; Y-P Chiu; J-H Chia; A-J Kuo; C-F Sun
Journal:  J Hosp Infect       Date:  2002-05       Impact factor: 3.926

Review 5.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

6.  Characteristics of Serratia marcescens containing a plasmid coding for gentamicin resistance in nosocomial infections.

Authors:  J F John; W F McNeill
Journal:  J Infect Dis       Date:  1981-06       Impact factor: 5.226

7.  Epidemiological analysis of imipenem-resistant Serratia marcescens in hospitalized patients.

Authors:  N Troillet; Y Carmeli; L Venkataraman; P DeGirolami; M H Samore
Journal:  J Hosp Infect       Date:  1999-05       Impact factor: 3.926

8.  Postoperative Serratia marcescens wound infections traced to an out-of-hospital source.

Authors:  D J Passaro; L Waring; R Armstrong; F Bolding; B Bouvier; J Rosenberg; A W Reingold; M McQuitty; S M Philpott; W R Jarvis; S B Werner; L S Tompkins; D J Vugia
Journal:  J Infect Dis       Date:  1997-04       Impact factor: 5.226

9.  DNA polymorphism of Mycobacterium abscessus analyzed by infrequent-restriction-site polymerase chain reaction.

Authors:  L H Su; J H Chia; H S Leu; S W Cheng; A J Kuo; C F Sun; T L Wu
Journal:  Chang Gung Med J       Date:  2000-08

10.  An outbreak of Serratia marcescens infections related to contaminated chlorhexidine.

Authors:  P Vigeant; V G Loo; C Bertrand; C Dixon; R Hollis; M A Pfaller; A P McLean; D J Briedis; T M Perl; H G Robson
Journal:  Infect Control Hosp Epidemiol       Date:  1998-10       Impact factor: 3.254

View more
  23 in total

1.  Pseudohemoptysis in an elderly due to Serratia marcescens pneumonitis.

Authors:  Manish Ranjan; Santosh Karade; Sourav Sen; V Srinivas
Journal:  Med J Armed Forces India       Date:  2017-10-05

2.  [Nosocomial infections in urology].

Authors:  H Piechota; A Kramer
Journal:  Urologe A       Date:  2014-10       Impact factor: 0.639

3.  New flagellin gene for Salmonella enterica serovar Typhi from the East Indonesian archipelago.

Authors:  Mochammad Hatta; Andi R Sultan; Rob Pastoor; Henk L Smits
Journal:  Am J Trop Med Hyg       Date:  2011-03       Impact factor: 2.345

4.  Requirement for Serratia marcescens cytolysin in a murine model of hemorrhagic pneumonia.

Authors:  Norberto González-Juarbe; Chris A Mares; Cecilia A Hinojosa; Jorge L Medina; Angelene Cantwell; Peter H Dube; Carlos J Orihuela; Molly A Bergman
Journal:  Infect Immun       Date:  2014-11-24       Impact factor: 3.441

5.  Cysteine Biosynthesis Controls Serratia marcescens Phospholipase Activity.

Authors:  Mark T Anderson; Lindsay A Mitchell; Harry L T Mobley
Journal:  J Bacteriol       Date:  2017-07-25       Impact factor: 3.490

Review 6.  Serratia infections: from military experiments to current practice.

Authors:  Steven D Mahlen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

7.  Draft genome sequence of Serratia marcescens strain LCT-SM213.

Authors:  Yajuan Wang; Yanting Yuan; Lisha Zhou; Qingqing Su; Xiangqun Fang; Tianzhi Li; Junfeng Wang; De Chang; Longxiang Su; Guogang Xu; Yinghua Guo; Ruifu Yang; Changting Liu
Journal:  J Bacteriol       Date:  2012-08       Impact factor: 3.490

8.  Molecular epidemiology of Serratia marcescens in two hospitals in Gdańsk, Poland, over a 5-year period.

Authors:  Lukasz Naumiuk; Anna Baraniak; Marek Gniadkowski; Beata Krawczyk; Bartosz Rybak; Ewa Sadowy; Alfred Samet; Józef Kur
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

9.  Three-year follow-up of an outbreak of Serratia marcescens bacteriuria in a neurosurgical intensive care unit.

Authors:  Baek-Nam Kim; Soon-Im Choi; Nam-Hee Ryoo
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

10.  Population-based laboratory surveillance for Serratia species isolates in a large Canadian health region.

Authors:  K B Laupland; M D Parkins; D B Gregson; D L Church; T Ross; J D D Pitout
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-10-25       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.